N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19)
Clinical trial NCT04706416 · COMPLETED
Trial details
- NCT number
- NCT04706416
- Sponsor
- Quantinosis.ai LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-14
- Primary completion
- 2021-01-15
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.